Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade A 110.28 2.98% 3.19
EXAS closed up 2.98 percent on Friday, October 23, 2020, on 60 percent of normal volume. The bulls were able to push the stock to a new 52-week high.
Earnings due: Oct 29
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical EXAS trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
New 52 Week High Strength 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze Started Range Contraction 0.00%
Crossed Above 20 DMA Bullish 2.98%
180 Bullish Setup Bullish Swing Setup 2.98%
Pocket Pivot Bullish Swing Setup 2.98%
Fell Below 20 DMA Bearish 10.71%
Multiple of Ten Bearish Other 10.71%
Older End-of-Day Gignals for EXAS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Medicine Health Cancer Medical Tests Inflammatory Bowel Disease Pancreatic Cancer Colorectal Cancer Cancer Screening Diagnostic Gastroenterology Mayo Clinic Polyp

Is EXAS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 110.79
52 Week Low 35.25
Average Volume 1,854,024
200-Day Moving Average 83.97
50-Day Moving Average 89.11
20-Day Moving Average 105.02
10-Day Moving Average 105.00
Average True Range 4.75
ADX 34.03
+DI 31.62
-DI 16.72
Chandelier Exit (Long, 3 ATRs ) 96.55
Chandelier Exit (Short, 3 ATRs ) 86.10
Upper Bollinger Band 110.84
Lower Bollinger Band 99.20
Percent B (%b) 0.95
BandWidth 11.08
MACD Line 4.71
MACD Signal Line 5.31
MACD Histogram -0.5929
Fundamentals Value
Market Cap 16.56 Billion
Num Shares 150 Million
EPS -1.76
Price-to-Earnings (P/E) Ratio -62.55
Price-to-Sales 13.43
Price-to-Book 6.40
PEG Ratio -1.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 117.47
Resistance 3 (R3) 116.84 113.81 116.27
Resistance 2 (R2) 113.81 111.98 114.13 115.87
Resistance 1 (R1) 112.05 110.85 112.93 112.68 115.47
Pivot Point 109.02 109.02 109.47 109.34 109.02
Support 1 (S1) 107.26 107.19 108.14 107.89 105.09
Support 2 (S2) 104.23 106.06 104.55 104.69
Support 3 (S3) 102.47 104.23 104.29
Support 4 (S4) 103.10